DXCM
Dexcom Inc
MEDICAL DEVICES · HEALTHCARE
DexCom, Inc. is a prominent leader in diabetes management, renowned for its state-of-the-art continuous glucose monitoring (CGM) systems that empower patients to optimize their glucose levels effectively. Based in San Diego, California, with a manufacturing facility in Mesa, Arizona, the company is ...
$84.68
+1.99% (+$1.65)
Volume
2.49M
52W High
$92.59
52W Low
$54.11
Market Cap
$28.58B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.66
Whisper EPS
$0.71
8.1% above consensus
Last Quarter
$0.70
Current Streak
7 Beats
Avg Surprise (4Q)
+14.29%
Next Earnings Report
Reports in 43 days
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q2 2026
Jul 30, 2026
1-Day:
+11.95%
5-Day:
+16.64%
Q2 2026
Jul 29, 2026
1-Day:
-0.80%
5-Day:
+16.20%
Q1 2026
Apr 30, 2026
1-Day:
+3.02%
5-Day:
-0.12%
Q1 2026
Apr 23, 2026
1-Day:
-1.80%
5-Day:
-5.39%
Revenue & Financial Performance
Revenue Whisper
$1.35B
TWN Proprietary Estimate
Last Quarter Revenue
$1.31B
+13.1% YoY
Gross Margin
63.4%
Net Margin: 19.0%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q2'26 | $1.31B | +13.1% | 63.4% | 24.3% | $249.1M |
| Q1'26 | $1.19B | +15.1% | 63.0% | 21.4% | $199.5M |
| Q4'25 | $1.26B | +13.1% | 62.9% | 25.6% | $267.3M |
| Q3'25 | $1.21B | +21.6% | 60.5% | 20.1% | $283.8M |
| Q2'25 | $1.16B | +15.2% | 59.5% | 18.4% | $179.8M |
| Q1'25 | $1.04B | +12.5% | 56.9% | 12.9% | $105.4M |
| Q4'24 | $1.11B | +7.6% | 58.9% | 17.0% | $151.7M |
| Q3'24 | $994.2M | +2.0% | 59.7% | 15.3% | $134.6M |
Company Information
Symbol
DXCM
Company
Dexcom Inc
Market Cap
$28.58B
Sector
HEALTHCARE
Next Earnings
Oct 29, 2026
Also Reporting Soon
Companies reporting earnings around the same time as DXCM
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in MEDICAL DEVICES
Compare DXCM with competitors
Side-by-side earnings comparison